MAPK3 and colonic neoplasm: However, it was documented that TQ treatment activates JNK and ERK1/2 in DLD‐1 human colon cancer cells.40 Two studies also showed that JNK and p38MAPK were activated by TQ in prostate and pancreatic cancer cells, respectively.